Markets & Investing
Poll: 67% of Hong Kong and Singapore investors plan to invest in Chinese onshore bonds in 2019
Poll: 67% of Hong Kong and Singapore investors plan to invest in Chinese onshore bonds in 2019
Sentiment was driven by the upcoming Bloomberg Barclays Global Aggregate Index inclusion in April 2019.
Fintech investments crashed 65.6% to US$188m in 2018
However, the number of deals picked up 27% as deals diversified.
Hong Kong VC and tech deals go bigger as quality focus intensifies
SenseTime and Tinklabs closed billion-dollar funding rounds.
Family offices spar with VCs for Hong Kong's promising startups
One family office has devoted 15% of US$70m capital into tech investments.
Movie ticketing app Maoyan opens flat on debut
It closed at $14.64 from an IPO of $14.8.
Hong Kong Exchange Fund's 2018 investment income plunged 95% amidst heavy equity losses
The headline figure hit $13.9b compared to $264b in 2017.
Hong Kong M&A activity slumped in 2018
Mergers and acquisitions deals fell to 1,050 transactions with a combined value of US$87.93b in 2018, down from 1,252 transactions with a combined...
Alibaba-backed AI facial recognition startup Megvii mulls up to US$1b IPO
Its high-ticket clients include Lenovo, Ant Financial and the government.
Hong Kong-listed L'Occitane to buy skincare brand Elemis for US$900m
The luxury cosmetics firm is building its UK and US foothold.
Singapore SMEs turn to Hong Kong for short-lived IPO rally
However, they failed to sustain the momentum as they trade below offer prices.
Ztore.com hauls $62m in series B round
Funding proceeds will be used to launch its Ztore App.
Chinese production studio mulls Hong Kong IPO
Youhug Media's share sale could raise at least US$100m.
Hong Kong's IPO haul may hit up to $230b in 2019
The city's crammed IPO pipeline features a little over 200 applicants.
Hong Kong investors expect 1.9% lower returns compared to Asian peers
Expectations amidst investors were still 0.3% higher than the 9% forecast in 2017.
Hang Seng Index continues recovery with 6.8% gain in November
It could seal further muted gains by 2019.
Cancer testing startup Grail shies away from Hong Kong listing as it mulls US pivot
The weak performance of earlier biotech listings may be to blame.
Hong Kong's hottest IPOs lose steam as returns fall short
The 10 most popular stocks by retail subscription ratio fell 36% on average.
Read Here
Advertise
Sign Up
